Evidence map›Paper›PMID 31487907›Full record

ArticleCancers2019

Manoalide Preferentially Provides Antiproliferation of Oral Cancer Cells by Oxidative Stress-Mediated Apoptosis and DNA Damage.

Hui-Ru Wang, Jen-Yang Tang, Yen-Yun Wang, Ammad Ahmad Farooqi, Ching-Yu Yen, Shyng-Shiou F Yuan, Hurng-Wern Huang, Hsueh-Wei Chang

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 50 citations in OpenAlex.

  1. 6-Biomedicines · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Methanol Extract ofAntioxidants (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Journal of personalized medicine · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Hui-Ru WangInstitute of Biomedical Science, National Sun Yat-sen University, Kaohsiung 80424, Taiwan. whr0319@gmail.com.
Jen-Yang TangDepartment of Radiation Oncology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. reyata@kmu.edu.tw.
Yen-Yun WangCancer Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. wyy@kmu.edu.tw.
Ammad Ahmad FarooqiDepartment of Molecular Oncology, Institute of Biomedical and Genetic Engineering (IBGE), Islamabad 54000, Pakistan. ammadfarooqi@rlmclahore.com.
Ching-Yu YenDepartment of Oral and Maxillofacial Surgery Chi-Mei Medical Center, Tainan 71004, Taiwan. ycysmc@gmail.com.
Shyng-Shiou F YuanCancer Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. yuanssf@ms33.hinet.net.
Hurng-Wern HuangInstitute of Biomedical Science, National Sun Yat-sen University, Kaohsiung 80424, Taiwan. sting@mail.nsysu.edu.tw.
Hsueh-Wei ChangCancer Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. changhw@kmu.edu.tw.ORCID 0000-0003-0068-2366
Kaohsiung Medical University · TWNational Sun Yat-sen University · TWChi Mei Medical Center · TWInstitute of Biomedical and Genetic Engineering · PK

Funding

Chimei-KMU jointed project 108CM-KMU-11Health and welfare surcharge of tobacco products, the Ministry of Health and Welfare, Taiwan, Republic of China MOHW 108-TDU-B-212-124016Kaohsiung Medical University Hospital KMUH107-7R74Ministry of Science and Technology, Taiwan MOST 107-2311-B-214-003Ministry of Science and Technology, Taiwan MOST 107-2314-B-037-048Ministry of Science and Technology, Taiwan MOST 107-2320-B-037-016National Sun Yat-sen University-KMU Joint Research Project #NSYSUKMU 108-P001
6 · The paper itself

Abstract

Marine sponge-derived manoalide has a potent anti-inflammatory effect, but its potential application as an anti-cancer drug has not yet been extensively investigated. The purpose of this study is to evaluate the antiproliferative effects of manoalide on oral cancer cells. MTS assay at 24 h showed that manoalide inhibited the proliferation of six types of oral cancer cell lines (SCC9, HSC3, OC2, OECM-1, Ca9-22, and CAL 27) but did not affect the proliferation of normal oral cell line (human gingival fibroblasts (HGF-1)). Manoalide also inhibits the ATP production from 3D sphere formation of Ca9-22 and CAL 27 cells. Mechanically, manoalide induces subG1 accumulation in oral cancer cells. Manoalide also induces more annexin V expression in oral cancer Ca9-22 and CAL 27 cells than that of HGF-1 cells. Manoalide induces activation of caspase 3 (Cas 3), which is a hallmark of apoptosis in oral cancer cells, Ca9-22 and CAL 27. Inhibitors of Cas 8 and Cas 9 suppress manoalide-induced Cas 3 activation. Manoalide induces higher reactive oxygen species (ROS) productions in Ca9-22 and CAL 27 cells than in HGF-1 cells. This oxidative stress induction by manoalide is further supported by mitochondrial superoxide (MitoSOX) production and mitochondrial membrane potential (MitoMP) destruction in oral cancer cells. Subsequently, manoalide-induced oxidative stress leads to DNA damages, such as γH2AX and 8-oxo-2'-deoxyguanosine (8-oxodG), in oral cancer cells. Effects, such as enhanced antiproliferation, apoptosis, oxidative stress, and DNA damage, in manoalide-treated oral cancer cells were suppressed by inhibitors of oxidative stress or apoptosis, or both, such as

Indexed as

anticancer drugmarine spongenatural productoral cancer inhibition

Identifiers

PMID31487907
PMCPMC6770486
OpenAlexW2971395209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.